IRB’s and patients’ views on consent for research on medical practices

In the context of research on medical practices, which includes comparative effectiveness research and pragmatic clinical trials, empirical studies have begun to raise questions about the extent to which institutional review boards’ interpretations and applications of research regulations align with patients’ values. David Magnus, PhD is Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics and Medicine at Stanford University, where he is Director of the Stanford Center for Biomedical Ethics and co-Chair of the Ethics Committee for the Stanford Hospital. He is the former President of the Association of Bioethics Program Directors, and is the Editor in Chief of the American Journal of Bioethics.

Publication

 

 

Image courtesy of the interviewee


Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Digital natives in the classroom

Next Article

Multimedia informational aids for research on medical practices

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×